Skip to main content
Log in

Impact of tablet crushing on the dissolution of venetoclax

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Anzai M, Yasu T, Gando Y, Shirota M, Kobayashi M (2022) Increased blood levels of venetoclax due to intake of crushed venetoclax tablets. Ann Hematol 101(9):2097–2098. https://doi.org/10.1007/s00277-022-04871-2

    Article  CAS  Google Scholar 

  2. Yasu T, Gando Y, Nomura Y, Kosugi N, Kobayashi M (2022) Determination of venetoclax concentration in plasma using high-performance liquid chromatography. J Chromatogr Sci:bmac027. https://doi.org/10.1093/chromsci/bmac027

  3. Kanda Y (2013) Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant 48(3):452–458. https://doi.org/10.1038/bmt.2012.244

    Article  CAS  Google Scholar 

  4. Jermain SV, Brough C, Williams RO 3rd (2018) Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery - an update. Int J Pharm 535(1–2):379–392. https://doi.org/10.1016/j.ijpharm.2017.10.051

    Article  CAS  Google Scholar 

  5. Pas T, Verbert S, Appeltans B, Van den Mooter G (2020) The influence of crushing amorphous solid dispersion dosage forms on the in-vitro dissolution kinetics. Int J Pharm 573:118884. https://doi.org/10.1016/j.ijpharm.2019.118884

    Article  CAS  Google Scholar 

  6. AbbVie Inc. (2021) VENCLEXTA® prescribing information. https://www.rxabbvie.com/pdf/venclexta.pdf. Accessed 2022 Aug 29

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takeo Yasu.

Ethics declarations

Ethics approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yasu, T., Hikita, E., Gando, Y. et al. Impact of tablet crushing on the dissolution of venetoclax. Ann Hematol 102, 219–220 (2023). https://doi.org/10.1007/s00277-022-05014-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-022-05014-3

Navigation